{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:46:43Z","timestamp":1787579203051,"version":"build-2736575974"},"reference-count":8,"publisher":"CSIRO Publishing","issue":"6","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":666,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In August 2022, in response to a global mpox outbreak, the World Health Organization recommended the Vaccinia vaccination for at-risk people.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Case study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We describe a case of a HIV-negative bisexual man who developed a symptomatic mpox infection 13\u00a0weeks after completing a two-dose course of subcutaneous third-generation modified vaccinia Ankara vaccines. The case likely acquired his mpox infection in the USA; was diagnosed in Aotearoa, New Zealand; and was followed-up in Australia, as he was actively travelling during his infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case highlights the importance of maintaining clinical suspicion for mpox in people who present with consistent symptoms, even if they are fully vaccinated. Also, as he travelled around Aotearoa, New Zealand, and Australia during his infection, this case highlights how public health authorities and clinicians can cooperate across jurisdictional boundaries to support cases and minimise the risk of onward transmission.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/sh23139","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T19:31:32Z","timestamp":1697657492000},"page":"585-587","source":"Crossref","is-referenced-by-count":2,"title":["Case study: breakthrough mpox infection in Aotearoa New Zealand and Australia after completed two-dose course of subcutaneous modified vaccinia Ankara (MVA-BN) vaccines"],"prefix":"10.1071","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0657-9677","authenticated-orcid":true,"given":"Vincent J.","family":"Cornelisse","sequence":"first","affiliation":[{"name":"AKirketon Road Centre, NSW Health, Sydney, NSW, Australia."},{"name":"BThe Kirby Institute, University of NSW, Sydney, NSW, Australia."},{"name":"CMonash University, Melbourne, Vic., Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J. M.","family":"Kearley","sequence":"additional","affiliation":[{"name":"AKirketon Road Centre, NSW Health, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Vargas Castillo","sequence":"additional","affiliation":[{"name":"AKirketon Road Centre, NSW Health, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Macharg","sequence":"additional","affiliation":[{"name":"DQueenstown Medical Centre, Queenstown, Aotearoa, New Zealand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia A.","family":"McLaughlin","sequence":"additional","affiliation":[{"name":"ETe Whatu Ora Southern, National Public Health Service, Aotearoa, New Zealand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Jack","sequence":"additional","affiliation":[{"name":"ETe Whatu Ora Southern, National Public Health Service, Aotearoa, New Zealand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Swift","sequence":"additional","affiliation":[{"name":"FPublic Health Unit, South Eastern Sydney Local Health District, Sydney, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"67","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"key":"2025102615395028100_R1","unstructured":"World Health Organization. Disease outbreak news; monkeypox \u2013 United Kingdom of Great Britain and Northern Ireland; 2022. Available at https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2022-DON383. [cited 3 March 2023]"},{"key":"2025102615395028100_R2","unstructured":"World Health Organization. 2022-23 Mpox (Monkeypox) outbreak: global trends; 2023. Available at https:\/\/worldhealthorg.shinyapps.io\/mpx_global\/#1_Overview. [cited 27 March 2023]"},{"key":"2025102615395028100_R3"},{"issue":"1","key":"2025102615395028100_R4","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28077","article-title":"Is smallpox vaccination protective against human monkeypox?","volume":"95","author":"Moschese","year":"2023","journal-title":"J Med Virol"},{"issue":"2","key":"2025102615395028100_R5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jinf.2022.12.001","article-title":"Breakthrough monkeypox infection among individuals previously immunized with smallpox or monkeypox vaccination.","volume":"86","author":"Raccagni","year":"2023","journal-title":"J Infect"},{"issue":"20","key":"2025102615395028100_R6","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1001\/jama.2022.18320","article-title":"Human monkeypox virus infection in the immediate period after receiving modified vaccinia ankara vaccine.","volume":"328","author":"Hazra","year":"2022","journal-title":"JAMA"},{"issue":"50","key":"2025102615395028100_R7","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.50.2200882","article-title":"Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022.","volume":"27","author":"Merad","year":"2022","journal-title":"Euro Surveill"},{"issue":"26","key":"2025102615395028100_R8","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMc2211944","article-title":"Breakthrough infections after postexposure vaccination against mpox.","volume":"387","author":"Thy","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Sexual Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/20\/6\/585\/693270\/sh23139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/20\/6\/585\/693270\/sh23139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:39:59Z","timestamp":1761507599000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/sh\/article\/20\/6\/585\/86581\/Case-study-breakthrough-mpox-infection-in-Aotearoa"}},"subtitle":[],"editor":[{"given":"Darren","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12,12]]}},"URL":"https:\/\/doi.org\/10.1071\/sh23139","relation":{},"ISSN":["1448-5028","1449-8987"],"issn-type":[{"value":"1448-5028","type":"print"},{"value":"1449-8987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]}}}